Crest Nicholson (LON:CRST – Get Free Report)‘s stock had its “outperform” rating reaffirmed by Royal Bank Of Canada in a report issued on Tuesday,Digital Look reports. They presently have a GBX 95 target price on the stock. Royal Bank Of Canada’s price target would indicate a potential upside of 36.10% from the company’s previous close.
CRST has been the topic of a number of other reports. Berenberg Bank cut their target price on shares of Crest Nicholson from GBX 160 to GBX 86 and set a “hold” rating on the stock in a research note on Wednesday, April 22nd. Stifel Nicolaus reissued a “hold” rating and issued a GBX 125 price objective on shares of Crest Nicholson in a research report on Tuesday, April 21st. Jefferies Financial Group restated a “buy” rating and issued a GBX 112 price objective on shares of Crest Nicholson in a report on Tuesday, May 5th. JPMorgan Chase & Co. decreased their price objective on shares of Crest Nicholson from GBX 160 to GBX 80 and set a “neutral” rating for the company in a research report on Tuesday, June 16th. Finally, Deutsche Bank Aktiengesellschaft cut Crest Nicholson to a “hold” rating and cut their price target for the company from GBX 228 to GBX 79 in a research note on Wednesday, April 22nd. Three analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of GBX 109.57.
View Our Latest Research Report on Crest Nicholson
Crest Nicholson Price Performance
Crest Nicholson Company Profile
Crest Nicholson Holdings plc engages in building residential homes in the United Kingdom. It develops and sells apartments, houses, and commercial properties. The company was founded in 1963 and is headquartered in Addlestone, the United Kingdom.
See Also
- Five stocks we like better than Crest Nicholson
- How TeraWulf’s Anthropic Deal Booted Up a $19B AI Empire
- Small-Cap ETFs Poised for Big Growth as Rate Outlook Shifts
- Flash Crash or Cash? The AI Hardware Reset Investors Can’t Ignore
- As Employers Drop Obesity Drug Coverage, Hims & Hers Could Be the Winner
Receive News & Ratings for Crest Nicholson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crest Nicholson and related companies with MarketBeat.com's FREE daily email newsletter.
